Opella acquired by Clayton, Dubilier & Rice
Clayton, Dubilier & Rice acquired Opella, a France, United States & Global supplements brand, on Apr 30, 2025.
Preliminary: The EV/EBITDA is not yet independently verified.
Transaction summary
- Target
- Opella
- Acquirer
- Clayton, Dubilier & Rice
- Announced
- 2024-10-21
- Geography
- France, United States & Global
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- 50%
- First added
- 2026-10-31
- Latest update
- 2026-10-31
Value and multiples
100% enterprise value
EUR 16B
100% enterprise value | EUR
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
Approx. $17B USD using FX date 2024-10-21 at 1.0853 EUR/USD.
EV / revenue
3.09x
Period: varies by source
Basis: Estimated
EV / EBITDA
14x
Unverified
EBITDA basis not stated
Basis: Estimated
Basis
- Reported value: €16bn enterprise value. Multiples use revenue of €5.18bn (FY2023) and EBITDA of €1.14bn (FY2024E). CD&R bought a 50% controlling stake; €16bn is the enterprise value for the whole business.
Source summary
Sanofi press release, 21 Oct 2024 (exclusive negotiations with CD&R for Opella)
ConfirmedThe valuation of Opella is based on an enterprise value of c.€16 billion, corresponding to c.14 times 2024 estimated EBITDA.
Open sourceContinue your research
Related transaction comps
Vitabiotics acquired by Bain Capital
2026-07-24 · Confirmed
View transaction → consumer healthOnnit Labs, Inc. acquired by Unilever
2021-04-26 · Estimated
View transaction → consumer healthSmartyPants Vitamins acquired by Unilever
2020-11-25 · Estimated
View transaction → consumer healthNatrol LLC acquired by New Mountain Capital
2020-10-26 · Confirmed
View transaction →